These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23927643)

  • 1. Molecular magnetic resonance imaging of pulmonary fibrosis in mice.
    Caravan P; Yang Y; Zachariah R; Schmitt A; Mino-Kenudson M; Chen HH; Sosnovik DE; Dai G; Fuchs BC; Lanuti M
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1120-6. PubMed ID: 23927643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models.
    Polasek M; Fuchs BC; Uppal R; Schühle DT; Alford JK; Loving GS; Yamada S; Wei L; Lauwers GY; Guimaraes AR; Tanabe KK; Caravan P
    J Hepatol; 2012 Sep; 57(3):549-55. PubMed ID: 22634342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis.
    Désogère P; Tapias LF; Rietz TA; Rotile N; Blasi F; Day H; Elliott J; Fuchs BC; Lanuti M; Caravan P
    J Nucl Med; 2017 Dec; 58(12):1991-1996. PubMed ID: 28611243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular MRI of collagen to diagnose and stage liver fibrosis.
    Fuchs BC; Wang H; Yang Y; Wei L; Polasek M; Schühle DT; Lauwers GY; Parkar A; Sinskey AJ; Tanabe KK; Caravan P
    J Hepatol; 2013 Nov; 59(5):992-8. PubMed ID: 23838178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Positron Emission Tomography and Molecular Magnetic Resonance Imaging of Cardiopulmonary Fibrosis in a Mouse Model of Left Ventricular Dysfunction.
    Moon BF; Zhou IY; Ning Y; Chen YI; Le Fur M; Shuvaev S; Akam EA; Ma H; Solsona CM; Weigand-Whittier J; Rotile N; Hariri LP; Drummond M; Boice AT; Zygmont SE; Sharma Y; Warburton RR; Martin GL; Blanton RM; Fanburg BL; Hill NS; Caravan P; Penumatsa KC
    J Am Heart Assoc; 2024 Jul; 13(14):e034363. PubMed ID: 38979786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Endometriosis Lesions Using Gd-Based Collagen I Targeting Probe in Murine Models of Endometriosis.
    Talebloo N; Bernal MAO; Kenyon E; Mallett CL; Fazleabas A; Moore A
    Mol Imaging Biol; 2023 Oct; 25(5):833-843. PubMed ID: 37418136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
    Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
    Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models.
    Désogère P; Tapias LF; Hariri LP; Rotile NJ; Rietz TA; Probst CK; Blasi F; Day H; Mino-Kenudson M; Weinreb P; Violette SM; Fuchs BC; Tager AM; Lanuti M; Caravan P
    Sci Transl Med; 2017 Apr; 9(384):. PubMed ID: 28381537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
    Cai Y; Kimura S
    PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging, targeting and characterization of pulmonary fibrosis using intra-tracheal administration of gadolinium-based nanoparticles.
    Tassali N; Bianchi A; Lux F; Raffard G; Sanchez S; Tillement O; Crémillieux Y
    Contrast Media Mol Imaging; 2016 Sep; 11(5):396-404. PubMed ID: 27396584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer.
    Polasek M; Yang Y; Schühle DT; Yaseen MA; Kim YR; Sung YS; Guimaraes AR; Caravan P
    Sci Rep; 2017 Aug; 7(1):8114. PubMed ID: 28808290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of alveolitis and pulmonary fibrosis in rabbits with magnetic resonance imaging after intrabronchial administration of bleomycin.
    Kersjes W; Hildebrandt G; Cagil H; Schunk K; von Zitzewitz H; Schild H
    Invest Radiol; 1999 Jan; 34(1):13-21. PubMed ID: 9888049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function.
    Binks AP; Beyer M; Miller R; LeClair RJ
    Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.
    Egger C; Gérard C; Vidotto N; Accart N; Cannet C; Dunbar A; Tigani B; Piaia A; Jarai G; Jarman E; Schmid HA; Beckmann N
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(12):L1064-77. PubMed ID: 24727584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
    Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
    Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
    Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
    Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.